Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council

Update: 2023-10-26

Description

In this episode, National Pharmaceutical Council (NPC) President and CEO John O'Brien, PharmD, MPH, joins Real Chemistry’s Founder and Chairman, Jim Weiss, to discuss the pharmaceutical industry, the value assessment of medicines, the role of government in drug pricing and the importance of research in healthcare policy. Tune in to get the latest insights on the lack of clarity in government guidelines, the hostile environment for the pharmaceutical industry, the shift in benefits and the rise in patient costs, and the need for more transparency and value-based care.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Health Citizenship and the Evolution of Technology and Healthcare: Jane Sarasohn-Kahn, Health Economist

2024-09-2441:16

Embracing the Power of RNAi Therapeutics: Akshay Vaishnaw, Alnylam Pharmaceuticals

2024-07-2535:37

Cannesplaining Healthcare: Creating Award-Worthy Work through Insight and Originality

2024-07-0139:00

Cannesplaining Healthcare: Emphasizing the Importance of Creativity in Healthcare with Genentech Chief Marketing Officer, Dr. Erica Taylor

2024-06-2740:45

Cannesplaining Healthcare: Improving Patient Experiences Through Creativity & Innovation With President of Cannes Lions 2024 Pharma Jury, Collette Douaihy

2024-06-2530:07

The Art & Science of Cancer Care: A Holistic Approach

2024-06-1044:25

Fighting Health Worker Burnout with Privacy-Safe AI: Live from SXSW 2024

2024-04-2243:50

Cancer 2034: Innovations That Are Shaping the Face of Cancer - Live from SXSW 2024

2024-04-0844:53

Partnering to Unlock Hope for the Future of Cancer Care: Live from SXSW 2024

2024-03-2541:54

Advancing Medical Communications by Combining Data, Creativity and Human Expertise: Suzanne Jacobs, Real Chemistry & Trina Stonner, Avant Healthcare

2024-02-0629:31

Caregiving and Cancer Prevention: Dr. Karen Knudsen, The American Cancer Society & Jim Weiss, Real Chemistry

2023-12-1437:19

Using Generative AI to Bring New Perspectives to Medical Problem Solving: Peter Lee, Microsoft & Brandon Pletsch, Real Chemistry

2023-12-0745:08

Enhancing Healthcare Consistency Through AI: Ajit Singh, Artiman Ventures

2023-11-3040:58

Reshaping the Medical Communications World through AI: Jason Gardner, SVP, Head of Medical, Real Chemistry

2023-11-0920:57

Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council

2023-10-2647:55

Tackling Health Disinformation in the AI and Digital Age: Dr. Geeta Nayyar, Author, Dead Wrong

2023-10-1927:08

Valuing Empathy to Ensure Patient-Centered Healthcare Strategies: Javeria Shahab, 21GRAMS, a part of Real Chemistry

2023-09-1431:32

Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, M.D., Council of Advisors on Science and Technology

2023-09-0755:24

Pioneering Public-Private Partnerships to Tackle Complex Health Issues: Dr. Julie Gerberding, FNIH, Dr. Jay Bradner, FNIH & Jim Weiss, Real Chemistry

2023-07-2055:09

Analyzing the Impact of Data and Technology on Healthcare Commercialization: Mark Martin, Houlihan Lokey & Jim Weiss, Real Chemistry

2023-06-2637:46

00:00

Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council

#box-pro-ellipsis-173224739679674{-webkit-line-clamp:2;}Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council

Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council

Real Chemistry

Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O'Brien, National Pharmaceutical Council